Across oral, topical, intravenous (IV), intranasal, and liposomal/orobuccal routesand precursors such as Nacetylcysteine (NAC) and GlyNACevidence quality ranges from small randomized trials with surrogate outcomes to narrative reviews and case series
Thomas L, Eckhardt M, Langkopf E et al (2008) (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
Researchers are making progress with innovative technologies like microneedle patches
The administration of antioxidants at the onset of experimental diabetes has been demonstrated to mitigate renal injury in diabetic subjects [316, 317]
No study has systematically measured the duration of benefit after treatment cessation or established optimal retreatment intervals
Cell Chemical Biology, 25 (4), 447